tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ORGO Stock Latest News

Organogenesis Holdings Reports Record Revenue, Raises Guidance
Company AnnouncementsOrganogenesis Holdings Reports Record Revenue, Raises Guidance
2d ago
ORGO
Organogenesis Holdings’ New Study on Diabetic Foot Ulcers: A Potential Game-Changer?
PremiumCompany Announcements
Organogenesis Holdings’ New Study on Diabetic Foot Ulcers: A Potential Game-Changer?
12d ago
ORGO
Buy Rating for Organogenesis Holdings Despite Mixed Trial Results, Supported by Diversified Revenue and FDA Clearance Efforts
PremiumRatings
Buy Rating for Organogenesis Holdings Despite Mixed Trial Results, Supported by Diversified Revenue and FDA Clearance Efforts
1M ago
ORGO
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial
PremiumCompany Announcements
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial
1M ago
8K
ORGO
Organogenesis provides update on second Phase 3 ReNu study
PremiumThe Fly
Organogenesis provides update on second Phase 3 ReNu study
1M ago
ORGO
Buy Rating for Organogenesis Holdings Amid Favorable Medicare Pricing and Market Positioning
PremiumRatingsBuy Rating for Organogenesis Holdings Amid Favorable Medicare Pricing and Market Positioning
2M ago
ORGO
Organogenesis Holdings’ Earnings Call: Mixed Sentiments and Strategic Moves
Premium
Company Announcements
Organogenesis Holdings’ Earnings Call: Mixed Sentiments and Strategic Moves
3M ago
ORGO
Organogenesis Holdings Reports Mixed Q2 2025 Results
Premium
Company Announcements
Organogenesis Holdings Reports Mixed Q2 2025 Results
3M ago
ORGO
Organogenesis Amends Credit Agreement Amid Revenue Decline
PremiumCompany Announcements
Organogenesis Amends Credit Agreement Amid Revenue Decline
3M ago
8K
ORGO
MiMedx price target raised to $12 from $11 at Cantor Fitzgerald
PremiumThe Fly
MiMedx price target raised to $12 from $11 at Cantor Fitzgerald
3M ago
MDXG
ORGO
Video: Why Organogenesis And MiMedx Are Sinking Today
PremiumThe Fly
Video: Why Organogenesis And MiMedx Are Sinking Today
4M ago
MDXG
ORGO
Organogenesis ‘pleased’ with CMS proposal on skin substitute
PremiumThe Fly
Organogenesis ‘pleased’ with CMS proposal on skin substitute
4M ago
ORGO
Organogenesis applauds CMS for proposed new payment for CTPs
PremiumThe FlyOrganogenesis applauds CMS for proposed new payment for CTPs
4M ago
ORGO
Organogenesis selloff on CMS proposal ‘may be incorrect,’ says BTIG
Premium
The Fly
Organogenesis selloff on CMS proposal ‘may be incorrect,’ says BTIG
4M ago
MDXG
ORGO
Organogenesis, MiMedx fall after CMS rule to cut skin substitutes spending
Premium
The Fly
Organogenesis, MiMedx fall after CMS rule to cut skin substitutes spending
4M ago
MDXG
ORGO
Organogenesis Holdings Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Organogenesis Holdings Approves Key Proposals at Annual Meeting
5M ago
8K
ORGO
Buy Rating for Organogenesis: Favorable Medicare Pricing and Attractive Valuation Signal Growth Potential
PremiumRatings
Buy Rating for Organogenesis: Favorable Medicare Pricing and Attractive Valuation Signal Growth Potential
5M ago
ORGO
Hold Rating Maintained for Organogenesis Holdings Amid Uncertainty in Coverage and Sales Projections
PremiumRatings
Hold Rating Maintained for Organogenesis Holdings Amid Uncertainty in Coverage and Sales Projections
6M ago
ORGO
Organogenesis Faces Challenges but Sees Growth Potential
PremiumCompany Announcements
Organogenesis Faces Challenges but Sees Growth Potential
6M ago
ORGO
Organogenesis Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsOrganogenesis Reports Q1 2025 Financial Results
6M ago
ORGO
Organogenesis reports Q1 EPS (17c), consensus (3c)
Premium
The Fly
Organogenesis reports Q1 EPS (17c), consensus (3c)
6M ago
ORGO
Organogenesis backs FY25 revenue view $480M-$535M, consensus $549.3M
Premium
The Fly
Organogenesis backs FY25 revenue view $480M-$535M, consensus $549.3M
6M ago
ORGO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >